Sinopharm Group Co. Ltd. (HKG:1099)
Hong Kong
· Delayed Price · Currency is HKD | Market Cap | 49.28B |
| Revenue (ttm) | 652.76B |
| Net Income (ttm) | 8.08B |
| Shares Out | 3.12B |
| EPS (ttm) | 2.58 |
| PE Ratio | 6.12 |
| Forward PE | 5.43 |
| Dividend | 0.80 (5.04%) |
| Ex-Dividend Date | Jun 23, 2026 |
| Volume | 12,069,698 |
| Average Volume | 7,877,885 |
| Open | 16.12 |
| Previous Close | 15.98 |
| Day's Range | 15.73 - 16.12 |
| 52-Week Range | 15.28 - 22.34 |
| Beta | 0.45 |
| RSI | 28.43 |
| Earnings Date | Aug 28, 2026 |
About Sinopharm Group
Sinopharm Group Co. Ltd., together with its subsidiaries, engages in the wholesale and retail of pharmaceutical and healthcare products, and medical devices in the People’s Republic of China. The company operates through four segments: Pharmaceutical Distribution, Medical Devices Distribution, Retail Pharmacy, and Other Business. The Pharmaceutical Distribution segment distributes pharmaceutical products to hospitals, other distributors, retail pharmacy stores, and clinics. This segment also offers distribution, logistics, and other value-added... [Read more]
Financial Performance
In 2025, Sinopharm Group's revenue was 575.17 billion, a decrease of -1.60% compared to the previous year's 584.51 billion. Earnings were 7.16 billion, an increase of 1.50%.
Financial numbers in CNY Financial StatementsAnalyst Forecast
According to 13 analysts, the average rating for 1099 stock is "Buy." The 12-month stock price target is $23.12, which is an increase of 46.42% from the latest price.
News
Sinopharm Group Earnings release: Q1 2026
Sinopharm Group released its Q1 2026 earnings on April 22, 2026, summarizing the period's financial results.
Sinopharm Group Earnings release: Q4 2025
Sinopharm Group released its Q4 2025 earnings on March 22, 2026, summarizing the period's financial results.
Sinopharm Group Slides: Q4 2025
Sinopharm Group has posted slides in relation to its Q4 2025 quarterly earnings report, which was published on March 22, 2026.
Sinopharm Group Annual report: Q4 2025
Sinopharm Group has published its Q4 2025 annual report on March 22, 2026.
Sinopharm Group Earnings release: Q3 2025
Sinopharm Group released its Q3 2025 earnings on October 26, 2025, summarizing the period's financial results.
Sinopharm Group Quarterly report: Q2 2025
Sinopharm Group has published its Q2 2025 quarterly earnings report on August 22, 2025.
Sinopharm Group Earnings release: Q2 2025
Sinopharm Group released its Q2 2025 earnings on August 22, 2025, summarizing the period's financial results.
Sinopharm Group Slides: Q2 2025
Sinopharm Group has posted slides in relation to its Q2 2025 quarterly earnings report, which was published on August 22, 2025.
Here Are All the COVID-19 Vaccines Currently in Clinical Testing
Leaders and laggards in the COVID-19 vaccine race -- and how likely they are to win approval.